MP32-05 MEDICARE ACO ENROLLMENT AND THE PREVALENCE OF PROSTATE CANCER SCREENING
Matthew J. Resnick(Vanderbilt University Medical Center), David F. Penson(Geriatric Research Education and Clinical Center), Mark Tyson(Nashville Oncology Associates), Amy J. Graves(Vanderbilt University), Melinda Buntin, Daniel Lee(Nashville Oncology Associates), Robert Gambrel
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532